D000306DisordersC04.588.322.078.265C19.053.098.265C19.053.347.500C19.344.078.265450.993281Adrenal Cortex NeoplasmsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson30413322Tierney JF, Vogle A, Poirier J, Min IM, Finnerty B, Zarnegar R, Pappas SG, Scognamiglio T, Ghai R, Gattuso P, Fahey TJ, Keutgen XMSurgeryExpression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study. Surgery. 2019 01; 165(1):196-201.Surgery2018-11-07T00:00:002018Expression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study.31361313Tierney JF, Chivukula SV, Poirier J, Pappas SG, Schadde E, Hertl M, Kebebew E, Keutgen XThe Journal of clinical endocrinology and metabolismNational Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress? J Clin Endocrinol Metab. 2019 12 01; 104(12):5948-5956.J Clin Endocrinol Metab2019-12-01T00:00:002019National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress?true1Assistant ProfessorAssistant ProfessorSameerPanjwaniSameer Panjwani350074Panjwani, SameerAssistant Professor30343951Glenn JA, Else T, Hughes DT, Cohen MS, Jolly S, Giordano TJ, Worden FP, Gauger PG, Hammer GD, Miller BSSurgeryLongitudinal patterns of recurrence in patients with adrenocortical carcinoma. Surgery. 2019 01; 165(1):186-195.Surgery2018-10-19T00:00:002018Longitudinal patterns of recurrence in patients with adrenocortical carcinoma.true1ProfessorProfessorMarkCohenMark Cohen41.87352120000000-87.66713820000000349059Cohen, MarkProfessorPathologyPaoloGattusoPaolo Gattuso349288Gattuso, PaoloProfessorSurgeryErikSchaddeErik Schadde349637Schadde, ErikAssistant Professor6Assistant Professor4Professor32111342Skertich NJ, Tierney JF, Chivukula SV, Babazadeh NT, Hertl M, Poirier J, Keutgen XMAmerican journal of surgeryRisk factors associated with positive resection margins in patients with adrenocortical carcinoma. Am J Surg. 2020 10; 220(4):932-937.Am J Surg2020-02-22T00:00:002020Risk factors associated with positive resection margins in patients with adrenocortical carcinoma.32683062Tierney JF, Vogle A, Finnerty B, Zarnegar R, Ghai R, Gattuso P, Fahey TJ, Keutgen XMThe Journal of surgical researchIndoleamine 2,3-Dioxygenase-1 Expression in Adrenocortical Carcinoma. J Surg Res. 2020 12; 256:90-95.J Surg Res2020-07-16T00:00:002020Indoleamine 2,3-Dioxygenase-1 Expression in Adrenocortical Carcinoma.0.6309750.1702814research area of0.7736980.1287448subject area forOrthopedic SurgeryFamily MedicineRush University, Rush Medical Collegetrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor